Grounded News
Signal, from the source.
Health, pharma, and medical-science headlines pulled from primary sources only — regulators, public-health agencies, peer-reviewed journals, and preprint servers. Nothing here is rewritten, summarized, or spun by this site: every headline is the source's own words and links straight to it. Subscribe via RSS.
Snapshot from the last site build (October 6, 2026 UTC) — rebuilt daily. For breaking news, go to the sources themselves.
Regulators & agencies
FDA U.S. Food & Drug Administration — press announcements
- FDA Seeks Public Input to Support Ibogaine Research Oct 5, 2026
The U.S. Food and Drug Administration today announced a request for information (RFI) describing approaches the agency is considering for the design of early-phase clinical trials of ibogaine drug products and seeking public input on those approaches.
- FDA Approves First Heart Valve Designed to Grow with Children Oct 1, 2026
The U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease.
- FDA Launches Nationwide Effort to Expand Scientific Expertise and Consumer Voices to Advisory Committees Sep 30, 2026
The U.S. Food and Drug Administration today announced a broad, nationwide recruitment effort to expand the range of qualified voices and perspectives on its advisory committees— the independent bodies that inform some of the most consequential decisions in…
- FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme Sep 29, 2026
The U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals.
- FDA Approves First Treatment for MCT8 Deficiency Sep 28, 2026
The U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and…
- FDA intends to evaluate changes to the PMTA regulatory framework Sep 28, 2026
FDA is carefully reviewing its experience implementing the Premarket Tobacco Product Application (PMTA) rule, as well as recent judicial developments, including a federal lawsuit filed in the U.S. District Court for the Northern District of Texas challenging…
- Federal Court Enters Consent Decree Against Gold Star Distribution, Inc. Following Persistent Insanitary Warehouse Conditions Sep 23, 2026
A U.S. Food and Drug Administration investigation resulted in a federal court order, dated Sept. 21, 2026, stopping a warehouse operator from distributing FDA-regulated products including food, drugs, medical devices, and cosmetics until it fixes its…
- FDA Updates Regulations to Advance Innovative Alternatives to Animal Testing Sep 21, 2026
The FDA today issued a direct final rule that updates its regulations to clarify that non-animal methods can be used where appropriate for testing the safety of drugs and biological products intended for human use before they’re tried in humans.
WHO World Health Organization — news
- WHO Director-General visits Jordan to recognize strong collaboration on health system delivery, emergency relief and advancing mental health Feb 25, 2026
The Director-General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, today concluded the first day of his two-day State visit to the Hashemite Kingdom of Jordan, underscoring the strong partnership between WHO and Jordan across the areas of…
- WHO statement on notification of withdrawal of the United States Jan 24, 2026
WHO regrets the United States’ notification of withdrawal from WHO – a decision that makes both the United States and the world less safe. The notification of withdrawal raises issues that will be considered by the WHO Executive Board at its regular meeting…
- Paying tribute to David Nabarro Jul 30, 2025
Tribute to Dr David Nabarro
- Timor-Leste certified malaria-free by WHO Jul 23, 2025
The World Health Organization (WHO) has certified Timor-Leste as malaria-free, a remarkable achievement for a country that prioritized the disease and embarked on a concerted, nation-wide response shortly after gaining independence in 2002. “WHO congratulates…
- African Union and World Health Organization renew strategic partnership to drive impact and strengthen health systems in Africa May 24, 2025
The World Health Organization (WHO) and the African Union (AU) Commission renewed their longstanding strategic partnership today with the signing of an updated Memorandum of Understanding (MoU) on the sidelines of the 78th World Health Assembly in Geneva.…
- WHO’s strategic engagement with philanthropies: advancing global health and resilient health systems May 19, 2025
Philanthropic support plays a vital role in enabling countries to build stronger health systems and advance towards health equity. From vaccine equity and pandemic preparedness to primary health care, the contributions of philanthropic partners help drive…
- Worldwide rally for maternal and newborn health marks World Health Day 2025 Apr 10, 2025
On the occasion of the World Health Day 2025 dedicated to the theme of Healthier beginnings, hopeful futures, over 100 global WHO offices have organized wide-ranging public advocacy actions in collaboration with Member States, communities, health workers,…
- Strengthening public health across Lebanon with EIB Global Apr 1, 2025
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), and Thomas Östros, Vice-President of the European Investment Bank (EIB Global), met at the EIB Group Forum in Luxembourg and signed an agreement for a €10 million grant to…
CMS U.S. Centers for Medicare & Medicaid Services — newsroom
- New Regulations Make It Easier to Find, Compare, and Report Healthcare Pricing and Coverage Information
New Regulations Make It Easier to Find, Compare, and Report Healthcare Pricing and Coverage Information
- Transparency in Coverage Final Rules (CMS 9882-F)
Transparency in Coverage Final Rules (CMS 9882-F) Introduction
- Medicare Improvement Fund Premium Rebate Frequently Asked Questions
Medicare Improvement Fund Premium Rebate Frequently Asked Questions Q: What will the Medicare Improvement Fund do for Medicare beneficiaries? A: The Administration is making a $90 Premium Rebate available for Part B premiums to certain Medicare beneficiaries…
- Trump Administration Announces $7.2 Million to Expand Ambulance-Based Telemedicine and Upgrade Emergency Communications Across South Dakota
Trump Administration Announces $7.2 Million to Expand Ambulance-Based Telemedicine and Upgrade Emergency Communications Across South Dakota This federal investment will help South Dakota's rural ambulance crews reach patients faster, share critical health…
- CMS Convenes Certified Independent Dispute Resolution Entity Leaders to Discuss Ways to Improve the Federal Program
CMS Convenes Certified Independent Dispute Resolution Entity Leaders to Discuss Ways to Improve the Federal Program
- Trump Administration Announces Nearly $55 Million to Expand Rural Maternal and Emergency Care, Cancer Screening, and Alabama’s Rural Healthcare Workforce
Trump Administration Announces Nearly $55 Million to Expand Rural Maternal and Emergency Care, Cancer Screening, and Alabama’s Rural Healthcare Workforce This federal investment will support 34 grants including maternal care networks and increase access to…
Journals
Nature Medicine Nature Medicine — latest research & news
- MAGIC: an international network for evaluating generative artificial intelligence in global health Oct 6, 2026
- An open vision-language model for diverse medical applications Oct 6, 2026
- Extended follow-up of in vivo BCMA CAR-T therapy in relapsed/refractory multiple myeloma Oct 6, 2026
- Global and regional reference curves for pain across the lifespan in 6.1 million individuals in 118 countries Oct 5, 2026
- Oral small-molecule GLP-1RA safiglipron versus dapagliflozin in type 2 diabetes: a randomized, double-blind, active-comparator-controlled phase 3 trial Oct 5, 2026
- The missing links in agentic AI autonomy Oct 2, 2026
- Small quantity lipid-based nutritional supplementation and measles vaccination coverage in children aged 6−23 months: a pragmatic cluster-randomized trial Oct 2, 2026
- Urine cell-free RNA for bladder cancer detection and treatment response prediction Oct 2, 2026
Preprints
medRxiv medRxiv — health-sciences preprints (not yet peer-reviewed)
- A detectability floor for treatment-response labels in rheumatology transcriptomics Oct 6, 2026
Objectives. Before-and-after transcriptomics in rheumatic disease often yields no reproducible treatment signal, though disease-state stratification is robust. We asked whether exposure and response-prediction labels fall below the detection floor of the…
- Towards a Transactional Understanding of Stress and Coping Among Nursing Students: A qualitative interview study Oct 6, 2026
Introduction: Nursing students experience stress arising from demanding academic requirements and emotionally challenging clinical placements, which may affect wellbeing, learning, and programme retention. This study explored perceptions of stress, its…
- Acquisition Speed versus Spatial Resolution in Ultra-High-Resolution Photon-Counting CT: Phantom Study to Guide Protocol Development Oct 6, 2026
Faster ultrahigh-resolution (UHR) photon-counting CT acquisitions facilitate breath-hold imaging, but identical reconstruction settings may conceal differences in spatial resolution. To assess spatial resolution and depiction of small airways and venous…
- Predicting Cervical Cancer Screening Utilization Among Women of Reproductive Age in Ethiopia Using Supervised Machine Learning: A Nationally Representative 2024/25 EDHS Study Oct 6, 2026
Abstract Background: Cervical cancer is a leading malignancy and mortality cause among Ethiopian women. Despite screening expansions coverage remains low. Traditional models miss complex determinants. This study aimed to develop machine learning models to…
- Overdose-related communication in Connecticut: reported receipt, perceived utility, and responses among overdose prevention and response professionals Oct 6, 2026
Background Timely overdose response depends not only on surveillance systems that detect overdose clusters, but also on communication pathways that deliver actionable information to the professionals positioned to respond. Understanding which overdose-related…
- Diabetes Polygenic Scores Predict Glycemic Indices and Insulin Use in Individuals with Atypical Diabetes Oct 6, 2026
Aims/Hypothesis: Atypical forms of diabetes often provide diagnostic challenges and are suboptimally treated. We sought to determine whether type 1 and 2 diabetes polygenic scores (PS) would help improve classification of islet autoantibody-negative (IAb-)…
- Right Versus Left Ventricular Myofiber Orientation in Various Congenital Heart Diseases Analyzed with X-Ray Phase-Contrast Tomography Oct 6, 2026
BACKGROUND: While the systemic right and left ventricles have different functional prognoses, only a limited number of reports have addressed their myocardial architecture. This study analyzed myofiber orientation of human specimens with various congenital…
- Prediction of in-hospital mortality at a 72-hour intensive care landmark in patients with sepsis and pre-existing hypertension: development and external validation Oct 6, 2026
Abstract Background: In patients with sepsis and pre-existing hypertension, admission findings may not adequately describe the subsequent course of circulatory support and organ dysfunction. We developed and externally validated a model to reassess…
Honesty note: NIH, npj Digital Medicine didn't answer when this build fetched the feeds — those sources are simply missing today rather than silently substituted.
This page is an automated, unedited aggregation of publicly available RSS feeds, refreshed when the site rebuilds. Headlines and summaries belong to their sources. Inclusion is not endorsement in either direction, preprints (medRxiv) are not yet peer-reviewed, and nothing on this page is medical advice.